Log In
Print
BCIQ
Print
Print this Print this
 

ASLAN002, BMS-777607

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionC-Met tyrosine kinase inhibitor
Molecular Target c-Met receptor tyrosine kinase
Mechanism of Actionc-Met receptor tyrosine kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Aslan Pharmaceuticals Pte. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today